Role of hyperglycemia in nitrotyrosine postprandial generation

Diabetes Care

Volumn 25, Issue 8, 2002, Pages 1439-1443

  Ceriello, Antonio ^a   Quagliaro, Lisa ^b   Catone, Barbara ^a   Pascon, Roberta ^a   Piazzola, Marta ^a   Bais, Bruno ^a   Marra, Giampiero ^c   Tonutti, Laura ^d   Taboga, Claudio ^d   Motz, Enrico ^a  

^a UNIVERSITY OF UDINE   (Italy)

^b Morpurgo Hofman Research Laboratory on Aging   (Italy)

^c NOVO NORDISK A S   (Denmark)

^d UNIVERSITY HOSPITAL OF UDINE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; INSULIN; INSULIN ASPART; TRIACYLGLYCEROL; 3-NITROTYROSINE; BIOLOGICAL MARKER; DRUG DERIVATIVE; TYROSINE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FUNCTION TEST; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; SAMPLE SIZE; TRIACYLGLYCEROL BLOOD LEVEL; BIOSYNTHESIS; BLOOD; FEMALE; MALE; METABOLISM; MIDDLE AGED; POSTPRANDIAL STATE;

BIOLOGICAL MARKERS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; OXIDATIVE STRESS; POSTPRANDIAL PERIOD; TRIGLYCERIDES; TYROSINE;

EID: 0036674993     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.25.8.1439     Document Type: Article

References (36)

1. Garcia MJ, McNamara PM, Gordon T, Kannel WB: Morbidity and mortality in diabetics in the Framingham population: sixteen-year follow up study. Diabetes 23:105-111, 1974
2. Zilversmit DB: Atherogenesis a post-prandial phenomenon. Circulation 60:473-485, 1979
3. Ebenbichler CF, Kirchmair R, Egger C, Patsch JR: Postprandial state and atherosclerosis. Curr Opin Lipidol 6:286-290, 1995
4. Lefebvre PJ, Scheen AJ: The postprandial state and risk of cardiovascular disease. Diabet Med 15 (Suppl. 4):S63-S68, 1998
5. Ceriello A: The post-prandial state and cardiovascular disease: relevance to diabetes mellitus. Diabete Metab Res Rev 16:125-132, 2000
6. Ceriello A: The emerging role of post-prandial hyperglycaemic spikes in the pathogenesis of diabetic complications. Diabet Med 15:188-193, 1998
7. Giugliano D, Ceriello A, Paolisso G: Oxidative stress and diabetic vascular complications. Diabetes Care 19:257-267, 1996
8. Ceriello A, Bortolotti N, Motz E, Crescentini A, Lizzio S, Russo A, Tonutti L, Taboga C: Meal-generated oxidative stress in type 2 diabetic patients. Diabetes Care 21:1529-1533, 1998
9. Cosentino F, Hishikawa K, Katusic ZS, Lüscher TF: High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation 96:25-28, 1997
10. Beckman JS, Koppenol WH: Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 271:C1424-C1437, 1996
11. Ischiropoulos H: Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species. Arch Biochem Biophys 356:1-11, 1998
12. Ceriello A, Mercuri F, Quagliaro L, Assaloni R, Motz E, Tonutti L, Taboga C: Detection of nitrotyrosine in the diabetic plasma: evidence of oxidative stress. Diabetologia 44:834-838, 2001
13. Marfella R, Quagliaro L, Nappo F, Ceriello A, Giugliano D: Acute hyperglycemia induces an oxidative stress in healthy subjects (Letter). J Clin Invest 108:635-636, 2001
14. Brange J, Volund A: Insulin analogs with improved pharmacokinetics profiles. Adv Drug Del Rev 35:307-335, 1999
15. Rosenfalck AM, Thorsby P, Kjems L, Birkeland K, Dejgaard A, Hanssen KF, Madsbad S: Improved postprandial glycaemic control with insulin aspart in diabetic patients treated with insulin. Acta Diabetol 37:41-46, 2000
16. Staprans I, Hardman DA, Pan XM, Feingold KR: Effect of oxidized lipids in the diet on oxidized lipid levels in postprandial serum chylomicrons of diabetic patients. Diabetes Care 22:300-306, 1999
17. Ter Steege JCA, Koster-Kamphuis L, Van Straaten E, Forget P, Buurman WA: Nitrotyrosine in plasma of celiac disease patients as detected by a new sandwich ELISA. Free Radical Biol Med 25:953-963, 1998
18. Sokolovsky M, Riordan JF, Valle BL: Tetranitromethane: a reagent for the nitration of tyrosil residues in proteins. Biochemistry 5:3582-3589, 1966
19. Secchi C, Berrini A, Borromeo V: An enzyme-linked immunosorbent assay for the determination of bovine prolactin in plasma. J Immunol Methods 136:17-22, 1991
20. Altman DG: Clinical trials. In Practical Statistics for Medical Research. Altman DG, Ed. London, Chapman & Hall, 1991, p. 440-476
21. Lyall F, Gibson JL, Greer IA, Brocman DE, Eis ALW, Myatt L: Increased nitrotyrosine in the diabetic placenta: evidence for oxidative stress. Diabetes Care 21:1753-1758, 1998
22. Thuraisingham RC, Nott CA, Dodd SM, Yaqoob MM: Increased nitrotyrosine staining in kidneys from patients with diabetic nephropathy. Kidney Int 57:1968-1972, 2000
23. Pennathur S, Wagner JD, Leeuwenburgh C, Litwak KN, Heinecke JW: A hydroxyl radical-like species oxidizes cynomolgus monkey artery wall proteins in early diabetic vascular disease. J Clin Invest 107:853-860, 2001
24. Ceriello A, Quagliaro L, D'Amico M, Di Filippo C, Martella R, Nappo F, Berrino L, Rossi F, Giugliano D: Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat. Diabetes 51:1076-1082, 2002
25. Groot PH, van Stiphout WA, Krauss XH, Jansen H, van Tol A, van Ramshorst E, Chin-On S, Hofman A, Cresswell SR, Havekes L: Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease. Arterioscler Thromb 11:653-662, 1991
26. Patsch JR, Hopferwieser T, Miesenboeck G, Muehlberger V, Knapp E, Dunn JK, Gotto AM Jr, Patsch W: The relationship of triglyceride metabolism and coronary artery disease: studies in the postprandial state. Arterioscler Thromb 12:1336-1345, 1992
27. Teno S, Uto Y, Nagashima H, Endoh Y, Iwamoto Y, Omori Y, Takizawa T: Association of postprandial hypertriglyceridemia and carotid intima-media thickness in patients with type 2 diabetes. Diabetes Care 23:1401-1406, 2000
28. Bonora E, Muggeo M: Postprandial blood glucose as a risk factor for cardiovascular disease in type 11 diabetes: the epidemiological evidence. Diabetologia 44:2107-2114, 2001
29. Moriel P, Abdalla DS: Nitrotyrosine bound to beta-VLDL-apoproteins: a biomarker of peroxynitrite formation in experimental atherosclerosis. Biochem Biophys Res Commun 232:332-335, 1997
30. Van der Vliet A, Smith D, O'Neill CA, Kaur H, Darley-Usmar V, Cross CE, Halliwell H: Interactions of peroxynitrite with human plasma and its constituents: oxidative damage and antioxidant depletion. Biochem J 303:295-301, 1994
31. MacMillan-Crow LA, Crow JP, Thompson JA: Peroxynitrite-mediated inactivation of manganese superoxide dismutase involves nitration and oxidation of critical tyrosine residues. Biochemistry 37:1613-1622, 1998
32. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA: Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A 87:1620-1624, 1990
33. Frustaci A, Kajstura J, Cimenti C, Jakoniuk I, Leri A, Maseri A, Nadal-Ginard B, Anversa P: Myocardial cell death in human diabetes. Circ Res 87:1123-1132, 2000
34. Kajstura J, Fiordaliso F, Andreoli AM, Li B, Cimenti S, Medow MS, Limana F, Nadal-Ginard B, Leri A, Anversa P: IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress. Diabetes 50:1414-1424, 2001
35. Mihm MJ, Jing L, Bauer JA: Nitrotyrosine causes selective vascular endothelial dysfunction and DNA damage. J Cardiovasc Pharmacol 36:182-187, 2000
36. Beckmann JS, Ye YZ, Anderson PG, Chen J, Accavitti MA, Tarpey MM, White CR: Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol Chem 375:81-88, 1994